<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY center_name="GEO" alias="GSE140741" accession="SRP230803">
    <IDENTIFIERS>
      <PRIMARY_ID>SRP230803</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject" label="primary">PRJNA590733</EXTERNAL_ID>
      <EXTERNAL_ID namespace="GEO">GSE140741</EXTERNAL_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>The lncRNA HHIP-AS1 is required for oncogenic SHH signaling in humans</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Transcriptome Analysis"/>
      <STUDY_ABSTRACT>Here we show that the non-conserved lncRNA HHIP-AS1 promotes tumorigenesis in human SHH-driven brain tumors, including medulloblastoma, atypical teratoid / rhabdoid tumors (AT/RT). We reveal that GLI2 regulates a bidirectional promoter shared between the well-characterized SHH regulator HHIP and HHIP-AS1. We found a novel regulatory lncRNA mechanism, termed blocking endogenous RNA (beRNA), extending the concept of competing endogenous RNA (ceRNA), where HHIP-AS1 binds its target DYCN1I2 to avoid miRNA-425-based degradation. Overall design: HHIP-AS1 knockdown</STUDY_ABSTRACT>
      <CENTER_PROJECT_NAME>GSE140741</CENTER_PROJECT_NAME>
    </DESCRIPTOR>
  </STUDY>
</STUDY_SET>
